AVINGTRANS PLC — Share Issue/Capital Change 2026

Jan 27, 2026

National Storage Mechanism | Additional information

RNS Number : 6193Q

Avingtrans PLC

27 January 2026

27 January 2026

Avingtrans Plc

("Avingtrans", the "Company", or the "Group")

Exercise of Options & TVR

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces that on 27 January 2026, the Company was notified of the exercise of 138,900 CSOP options over ordinary shares of 5p each in the Company ("Ordinary Shares") by certain non-PDMR employees pursuant to the Company's CSOP.

Issue of Equity

Application has been made for the admission to trading on AIM for the 138,900 new Ordinary Shares ("Admission"). It is expected that Admission will become effective on 4 February 2026.

Total Voting Rights

Following the issue of the 138,900 new Ordinary Shares, the Company will have a total of 33,269,322 Ordinary Shares in issue. The Company does not hold any shares in Treasury. 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The above information is provided by the Company in accordance with its obligations under the FCA's Disclosure Guidance and Transparency Rules

Enquiries:

Avingtrans plc	01354 692 391
Roger McDowell, Chairman Steve McQuillan, Chief Executive Officer Stephen King, Chief Financial Officer
Singer Capital Markets (Nominated Adviser and Broker)	020 7496 3000
Sara Hale
Alex Bond
Carl Diebitsch
IFC Advisory (Financial PR)	020 3934 6630
Graham Herring Tim Metcalfe Zach Cohen

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEUBSBRNAUAUAR